Literature DB >> 8224085

Giardia lamblia: post-translational processing and status of exposed cysteine residues in TSA 417, a variable surface antigen.

S B Aley1, F D Gillin.   

Abstract

Giardia lamblia develops and thrives within the harsh and variable environment of the human small intestine. To survive this environment, Giardia has evolved a unique family of antigenically variable, extremely cysteine-rich surface proteins. We have characterized the expression of one of these antigens, TSA 417, at the gene and protein levels. TSA 417 mRNA and protein were expressed at constant levels during both logarithmic growth and encystation. On the trophozoite surface, TSA 417 exists in two forms, an 85-kDa protein and a derived 66-kDa form. Both species have identical amino-terminal sequences that match the translated sequence of TSA 417 after removal of a predicted 17 amino acid signal peptide. Since TSA 417 is highly cysteine rich (ca. 12 mole%), we asked whether it was complexed with itself or with other molecules. Although we found no interchain disulfide bonds, there was substantial intrachain bonding that helped retain the gross structure of isolated TSA 417 after partial trypsin digestion. Because the hydropathy profile of TSA 417 suggested that most of the cysteine and all 29 of its conserved CXXC motifs are on the cell surface, we investigated whether TSA 417 might contain some of the free thiols previously shown to be on the trophozoite surface (Gillin et al., Molecular and Biochemical Parasitology, 13, 1-12, 1984). However, no free thiols were detected, either exposed on native TSA 417 or in the unfolded protein. The absence of free thiols and resistance to proteolytic digestion suggest that most of the cysteine residues are in intrachain bridges, probably either disulfide bonds or cysteine-metal complexes. This internal crosslinking may help explain the resistance of Giardia to proteases and other degradative enzymes in the intestinal fluid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224085     DOI: 10.1006/expr.1993.1087

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

Review 1.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Conformationally correct expression of membrane-anchored Toxoplasma gondii SAG1 in the primitive protozoan Giardia duodenalis.

Authors:  Matthias Marti; Yajie Li; Peter Köhler; Adrian B Hehl
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 3.  Antigenic variation in Giardia lamblia and the host's immune response.

Authors:  T E Nash
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

4.  The Giardia lamblia vsp gene repertoire: characteristics, genomic organization, and evolution.

Authors:  Rodney D Adam; Anuranjini Nigam; Vishwas Seshadri; Craig A Martens; Gregory A Farneth; Hilary G Morrison; Theodore E Nash; Stephen F Porcella; Rima Patel
Journal:  BMC Genomics       Date:  2010-07-09       Impact factor: 3.969

5.  A new family of giardial cysteine-rich non-VSP protein genes and a novel cyst protein.

Authors:  Barbara J Davids; David S Reiner; Shanda R Birkeland; Sarah P Preheim; Michael J Cipriano; Andrew G McArthur; Frances D Gillin
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  The proteome landscape of Giardia lamblia encystation.

Authors:  Carmen Faso; Sylvain Bischof; Adrian B Hehl
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Experimental verification of the identity of variant-specific surface proteins in Giardia lamblia trophozoites.

Authors:  Wei Li; Ashesh A Saraiya; Ching C Wang
Journal:  MBio       Date:  2013-05-21       Impact factor: 7.867

8.  Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins.

Authors:  Marianela C Serradell; Lucía L Rupil; Román A Martino; César G Prucca; Pedro G Carranza; Alicia Saura; Elmer A Fernández; Pablo R Gargantini; Albano H Tenaglia; Juan P Petiti; Renata R Tonelli; Nicolás Reinoso-Vizcaino; José Echenique; Luciana Berod; Eliane Piaggio; Bertrand Bellier; Tim Sparwasser; David Klatzmann; Hugo D Luján
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.